Our work is entirely funded by private donations – we receive no money from government. Your money will help us continue funding research into vitiligo and supporting people affected by the condition.
World Vitiligo Map
Your guide to the vitiligo community worldwide. Use the selector to filter by patient support groups, specialists, research centers, clinical trial locations, or World Vitiligo Day events.
Directory Information & Disclaimer
This free public directory gathers information from public sources to help connect our global community. Medical professionals and organizations listed are independent and not affiliated with or endorsed by the Vitiligo Research Foundation (VRF), and no fees are accepted for listings.
Because clinics, support groups, and specialists move or update their services over time, some information may occasionally become outdated. As a result, VRF cannot guarantee the complete accuracy or usefulness of listed third-party resources.
Help Us Keep the Map Accurate
Do you need to add a listing, update outdated details, or request a removal? Please reach out to us using the feedback form on our Contact Us page.
Search Map
78 records found for “NCT06804811” · show all
- A Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Children (6 to < 12 Years Old) With Nonsegmental Vitiligo
Phase: PHASE3
Intervention: Drug: Ruxolitinib Cream; Drug: Vehicle Cream
Status: Open now
Organizer: Incyte Corporation
Trial page: https://vrfoundation.org/trials/ruxolitinib-cream-for-children-ages-6-to-11Azienda Ospedale Universita Di Padova, Padua, 35100, Italy
1.855.463.3463
- A Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Children (6 to < 12 Years Old) With Nonsegmental Vitiligo
Phase: PHASE3
Intervention: Drug: Ruxolitinib Cream; Drug: Vehicle Cream
Status: Open now
Organizer: Incyte Corporation
Trial page: https://vrfoundation.org/trials/ruxolitinib-cream-for-children-ages-6-to-11Istituto Di Ricovero E Cura A Carattere Scientifico (Ircss), Roma, 00167, Italy
1.855.463.3463
- A Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Children (6 to < 12 Years Old) With Nonsegmental Vitiligo
Phase: PHASE3
Intervention: Drug: Ruxolitinib Cream; Drug: Vehicle Cream
Status: Open now
Organizer: Incyte Corporation
Trial page: https://vrfoundation.org/trials/ruxolitinib-cream-for-children-ages-6-to-11Irccs Ospedale Pediatrico Bambino Gesu, Rome, 00165, Italy
1.855.463.3463
- A Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Children (6 to < 12 Years Old) With Nonsegmental Vitiligo
Phase: PHASE3
Intervention: Drug: Ruxolitinib Cream; Drug: Vehicle Cream
Status: Open now
Organizer: Incyte Corporation
Trial page: https://vrfoundation.org/trials/ruxolitinib-cream-for-children-ages-6-to-11Amsterdam Umc Research Bv, Amsterdam, 1105 AZ, Netherlands
1.855.463.3463
- A Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Children (6 to < 12 Years Old) With Nonsegmental Vitiligo
Phase: PHASE3
Intervention: Drug: Ruxolitinib Cream; Drug: Vehicle Cream
Status: Open now
Organizer: Incyte Corporation
Trial page: https://vrfoundation.org/trials/ruxolitinib-cream-for-children-ages-6-to-11Care Clinic Sp. Z O.O., Katowice, 40-568, Poland
1.855.463.3463
- A Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Children (6 to < 12 Years Old) With Nonsegmental Vitiligo
Phase: PHASE3
Intervention: Drug: Ruxolitinib Cream; Drug: Vehicle Cream
Status: Open now
Organizer: Incyte Corporation
Trial page: https://vrfoundation.org/trials/ruxolitinib-cream-for-children-ages-6-to-11Diamond Clinic Specjalistyczne Poradnie Lekarskie, Krakow, 31-559, Poland
1.855.463.3463
- A Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Children (6 to < 12 Years Old) With Nonsegmental Vitiligo
Phase: PHASE3
Intervention: Drug: Ruxolitinib Cream; Drug: Vehicle Cream
Status: Open now
Organizer: Incyte Corporation
Trial page: https://vrfoundation.org/trials/ruxolitinib-cream-for-children-ages-6-to-11Dermedic Iwona Zdybska, Lublin, 20-607, Poland
1.855.463.3463
- A Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Children (6 to < 12 Years Old) With Nonsegmental Vitiligo
Phase: PHASE3
Intervention: Drug: Ruxolitinib Cream; Drug: Vehicle Cream
Status: Open now
Organizer: Incyte Corporation
Trial page: https://vrfoundation.org/trials/ruxolitinib-cream-for-children-ages-6-to-11Twoja Przychodnia - Medyczne Nowa Sol, Nowa Sól, 67-100, Poland
1.855.463.3463
- A Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Children (6 to < 12 Years Old) With Nonsegmental Vitiligo
Phase: PHASE3
Intervention: Drug: Ruxolitinib Cream; Drug: Vehicle Cream
Status: Open now
Organizer: Incyte Corporation
Trial page: https://vrfoundation.org/trials/ruxolitinib-cream-for-children-ages-6-to-11Uniwersytecki Szpital Kliniczny Im. Fryderyka Chopina W Rzeszowie, Rzeszów, 35-055, Poland
1.855.463.3463
- A Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Children (6 to < 12 Years Old) With Nonsegmental Vitiligo
Phase: PHASE3
Intervention: Drug: Ruxolitinib Cream; Drug: Vehicle Cream
Status: Open now
Organizer: Incyte Corporation
Trial page: https://vrfoundation.org/trials/ruxolitinib-cream-for-children-ages-6-to-11Twoja Przychodnia Scm, Szczecin, 71-500, Poland
1.855.463.3463
- A Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Children (6 to < 12 Years Old) With Nonsegmental Vitiligo
Phase: PHASE3
Intervention: Drug: Ruxolitinib Cream; Drug: Vehicle Cream
Status: Open now
Organizer: Incyte Corporation
Trial page: https://vrfoundation.org/trials/ruxolitinib-cream-for-children-ages-6-to-11Evimed Sp. Z O. O., Warsaw, 02-625, Poland
1.855.463.3463
- A Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Children (6 to < 12 Years Old) With Nonsegmental Vitiligo
Phase: PHASE3
Intervention: Drug: Ruxolitinib Cream; Drug: Vehicle Cream
Status: Open now
Organizer: Incyte Corporation
Trial page: https://vrfoundation.org/trials/ruxolitinib-cream-for-children-ages-6-to-11Centro Hospitalar E Universitario Coimbra, Coimbra, 3000-075, Portugal
1.855.463.3463
- A Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Children (6 to < 12 Years Old) With Nonsegmental Vitiligo
Phase: PHASE3
Intervention: Drug: Ruxolitinib Cream; Drug: Vehicle Cream
Status: Open now
Organizer: Incyte Corporation
Trial page: https://vrfoundation.org/trials/ruxolitinib-cream-for-children-ages-6-to-11Centro Hospitalar de Lisboa Central - Hospital Santo Antonio Dos Capuchos, Lisbon, 1169-050, Portugal
1.855.463.3463
- A Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Children (6 to < 12 Years Old) With Nonsegmental Vitiligo
Phase: PHASE3
Intervention: Drug: Ruxolitinib Cream; Drug: Vehicle Cream
Status: Open now
Organizer: Incyte Corporation
Trial page: https://vrfoundation.org/trials/ruxolitinib-cream-for-children-ages-6-to-11Hospital Universitari Germans Trias I Pujol, Badalona, 08916, Spain
1.855.463.3463
- A Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Children (6 to < 12 Years Old) With Nonsegmental Vitiligo
Phase: PHASE3
Intervention: Drug: Ruxolitinib Cream; Drug: Vehicle Cream
Status: Open now
Organizer: Incyte Corporation
Trial page: https://vrfoundation.org/trials/ruxolitinib-cream-for-children-ages-6-to-11Hospital de La Santa Creu I Sant Pau, Barcelona, 08026, Spain
1.855.463.3463
- A Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Children (6 to < 12 Years Old) With Nonsegmental Vitiligo
Phase: PHASE3
Intervention: Drug: Ruxolitinib Cream; Drug: Vehicle Cream
Status: Open now
Organizer: Incyte Corporation
Trial page: https://vrfoundation.org/trials/ruxolitinib-cream-for-children-ages-6-to-11Hospital Sant Joan de Deu Barcelona, Esplugues de Llobregat, 08950, Spain
1.855.463.3463
- A Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Children (6 to < 12 Years Old) With Nonsegmental Vitiligo
Phase: PHASE3
Intervention: Drug: Ruxolitinib Cream; Drug: Vehicle Cream
Status: Open now
Organizer: Incyte Corporation
Trial page: https://vrfoundation.org/trials/ruxolitinib-cream-for-children-ages-6-to-11Hospital Universitario Miguel Servet de Zaragoza, Zaragoza, 50009, Spain
1.855.463.3463
- A Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Children (6 to < 12 Years Old) With Nonsegmental Vitiligo
Phase: PHASE3
Intervention: Drug: Ruxolitinib Cream; Drug: Vehicle Cream
Status: Open now
Organizer: Incyte Corporation
Trial page: https://vrfoundation.org/trials/ruxolitinib-cream-for-children-ages-6-to-11Croydon University Hospital, Croydon, CR7 7YE, United Kingdom
1.855.463.3463
- A Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Children (6 to < 12 Years Old) With Nonsegmental Vitiligo
Phase: PHASE3
Intervention: Drug: Ruxolitinib Cream; Drug: Vehicle Cream
Status: Open now
Organizer: Incyte Corporation
Trial page: https://vrfoundation.org/trials/ruxolitinib-cream-for-children-ages-6-to-11The Royal London Hospital - Barts Health Nhs Trust, London, E1 1FR, United Kingdom
1.855.463.3463
- A Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Children (6 to < 12 Years Old) With Nonsegmental Vitiligo
Phase: PHASE3
Intervention: Drug: Ruxolitinib Cream; Drug: Vehicle Cream
Status: Open now
Organizer: Incyte Corporation
Trial page: https://vrfoundation.org/trials/ruxolitinib-cream-for-children-ages-6-to-11Guys Hospital, London, SE1 9RT, United Kingdom
1.855.463.3463
FAQOther Questions
- Any link between vitiligo and military service?
While there isn't specific research directly linking military service to the onset of vitiligo, it's critical to comprehend that vitiligo is a multifaceted disorder influenced b...
- How can I explain vitiligo to my children?
Vitiligo can be confusing for children because it doesn’t resemble an "illness" in the typical sense. Choosing the right way to explain it depends on your child’s age and maturi...
- Isn't it just a cosmetic disorder?
Contrary to popular belief, vitiligo is not merely a cosmetic issue but a complex autoimmune disorder that affects the body’s largest organ—along with other vital systems—and is...
Though it is not always easy to treat vitiligo, there is much to be gained by clearly understanding the diagnosis, the future implications, treatment options and their outcomes.
Many people deal with vitiligo while remaining in the public eye, maintaining a positive outlook, and having a successful career.
Copyright (C) Bodolóczki JúliaBy taking a little time to fill in the anonymous questionnaire, you can help researchers better understand and fight vitiligo.